These ten images can help ob/gyns recognize the additional information GBCA administration provides in MRIs.
Rola Saouaf, MD
Advertisement
Articles by Rola Saouaf, MD
Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration.
Concerns have been raised about the safety of GBCA. Experts review the latest data to support counseling of patients who may have repeated exposure.
Advertisement
Latest Updated Articles
Gadolinium-based contrast in breast MRI: What ob/gyns need to knowSeptember 19th 2019
8 examples of how GBCA improves MRIOctober 3rd 2019
The value of GBCA in MRI imagesNovember 4th 2019
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
2
Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals
3
Spotlighting the endometriosis, preeclampsia research gap in Black women, with Calbeth C. Alaribe, DMSc, MPH, PA-C
4
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
5